LONDON (Reuters) -U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion ...

Australia will "not compromise" on its policy to subsidise the cost of some medicines, the government said on Wednesday, ...

President Donald Trump's effort to reduce prices of prescription drugs amounts to price control since it’s not limited to ...

Fox News senior medical analyst Dr. Marc Siegel weighs in on President Donald Trump's pharmaceutical executive order aiming ...

While Trump has not yet turned to price controls to address America‘s absurdly high drug prices, Monday‘s executive order ...

President Donald Trump’s latest bid to slash prescription drug prices has once again stirred heated debate about the high ...

The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by ...

Trump spoke about a sweeping executive order he signed Monday that promised to lower prescription drug prices by between 59% ...

President Donald Trump's new health care initiative aims to reduce prescription drug costs by targeting pharmacy benefit managers, commonly known as PBMs.

The VanEck Biotech ETF offers lower risk with established companies, but 23% of AUM in speculative stocks poses a risk. Check ...

Trump signs executive order, discussed "overweight" friend who was taking the "fat shot drug." It wasn't confirmed whether he ...

Industry executives feel that the direct-to-government sales could open new channels, giving generic manufacturers some ...